BCRB 2018

First page Table of contents Next page Last page
0.Dublin1
1.1 VG_Introduction Dublin 20182
1.2 MK_Hallmarks of Cancer Dublin 201878
1.3 MK_Cell death Dublin 2018112
1.4 RC_Cell_surv 2018 Dublin152
1.5 MJ_Models_Dublin18_WS224
1.6 KH_Tumor growth and response to irradiation250
1.7 WD_Pathogenesis of NT effects 2018277
2.1 MJ_LQapproach_Dublin18_WS318
2.2 MK_MolBasisDNAdamageResponse Dublin 2018345
2.3 WD_NT radiosensitivity and fractionation 2018374
2.4 WD_NT overall treatment time 2018393
2.5 VG_HFAF Dublin 2018428
2.6a MJ_EQD2illumination16by9animated_new2_Dublin18_WS516
2.6b MJ_LQpractice_Dublin18_WS528
3.1 MJ_LETandRBE_Dublin18_WS546
3.2 MK_Oxygen effect and TME Dublin 2018574
3.3 KH_Clinical efforts to modify tumor hypoxia615
3.4 RC_Biological modifiers of normal tissue effects Dublin 2018644
3.5 WD_Volume effects in RT 2018752
4.1 MK_Biological Modifiers Preclinical Dublin 2018790
4.2 KH_Biological response modifiers in tumors829
4.3 MJ_DoseRespRels_Dublin18_WS856
4.4 VG_RT_CH Dublin 2018886
4.5_RC_Retreatement tolerance Dublin 2018926
4.6 VG_Funct Imag Dublin 20181014
5.1 Clinical side effects and their quantification1056
5.2 RC_Dose-rate & brachyther Dublin 20181090
5.3 VG_Hadron Dublin 20181152
5.4 MJ_RadnInducedMalig_Dublin18_WS1223
MJ_Handout_LQcorrDeriv_WS1261

Made with FlippingBook - Online catalogs